Bcg

BCG (Bacillus Calmette-Guérin) is a bacterial preparation used for intravesical administration. It is commonly associated with bladder cancer treatment and may help in certain immune-related therapies.

BCG is primarily used in the treatment of bladder cancer, particularly for non-muscle invasive bladder cancer. It is administered intravesically, meaning it is delivered directly into the bladder. This approach is designed to stimulate the immune system to target cancer cells. BCG may also be used in other immune-related therapies, though its primary application remains in bladder cancer treatment.

When used as directed, BCG can cause localized reactions such as bladder irritation, which may lead to symptoms like frequent urination, burning sensation, or blood in the urine. These effects are generally temporary and subside as the body adjusts to the treatment. Some individuals may experience systemic reactions, including fever or flu-like symptoms.

BCG should be handled with care to avoid contamination. It is important to follow proper hygiene practices and avoid contact with the eyes, mouth, and open wounds. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting BCG treatment. Regular monitoring may be required to assess the body's response to the treatment.

BCG may interact with certain medications that affect the immune system. It is advisable to consult a healthcare provider before combining BCG with other treatments. Alcohol and certain foods may not directly interact with BCG, but maintaining a healthy lifestyle can support overall treatment effectiveness.